Skip to main content
. Author manuscript; available in PMC: 2018 Feb 3.
Published in final edited form as: N Engl J Med. 2017 Jun 23;377(5):454–464. doi: 10.1056/NEJMoa1614359

Table 3.

Summary of Complete Remission.*

Variable Midostaurin Group (N = 360) Placebo Group (N = 357) P Value
Protocol-specified complete remission — no. (%) 212 (59) 191 (54) 0.15
Kaplan–Meier estimate of time to complete remission — days
 Median 35 35
 Range 20–60 20–60
*

Complete remission was defined as the presence of less than 5% blasts in the marrow or extramedullary leukemia, an absolute neutrophil count of more than 1000 per microliter, a platelet count of more than 100,000 per microliter, and the absence of blasts in the peripheral blood; in addition, per protocol, complete remission had to occur by day 60.

P value is two-sided and was calculated with the use of Fisher's exact test.